|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features |
| Swine Flu ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2009 / November 2009 / November 18, 2009 |
New anti-malaria vaccine found effective in children
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2009 Results
Adopt holistic approach for weight loss, says expert
Forget dieting or gruelling workout regimes -adopting a holistic approach to losing weight would be enough to feed your body the nourishment it craves for, says medical director of Greenwich Hospital. ANI
IVF babies at higher diabetes, obesity risk
A new study by scientists at Temple University in Philadelphia has shown that the DNA of babies conceived through IVF differs from that of other kids, putting them at higher risk of diseases such as diabetes and obesity later in life. ANI
Smoke food flavourings may be toxic to humans
One of the flavourings used to give smoke taste to meat, cheese or fish, could be toxic to humans, says the European Food Safety Authority (EFSA). ANI
Good news for smokers struggling to quit: an injectable vaccine has been developed that may help them kick the habit.
London, Nov 18 : Good news for smokers struggling to quit: an injectable vaccine has been developed that may help them kick the habit.
Smokers could soon have access to the vaccine following a deal between GlaxoSmithKline and Nabi Pharmaceuticals, the company that developed the drug.
The NicVAX vaccine creates anti-bodies that bind to nicotine molecules and stops them entering the blood flowing into the brain, where the pleasurable sensation is created.
Tests of the vaccine have shown that it can halve the number of smokers who go back to nicotine after trying to give it up.
The deal will see GSK paying 24 million pounds up front and 296 million pounds to Nabi.
"If approved this... technology could be a novel solution to help the millions of smokers who want to stop smoking and remain abstinent; a habit that is very well documented to be very hard to stop permanently," the Telegraph quoted Jean Stephenne, president of GSK's Biologicals division, as saying.
ANI
